PRODUCT LIST Active Pharma Ingredients API Acid Reflux Disorders Product Pharmacopoeia CAS No. Technical Document A Acotiamide Hydrochloride - 773092-05-0 - Almagate EP 66827-12-1 - Aluminum Hydroxide BP, USP 21645-51-2 - C Cimetidine - 51481-61-9 - D Dexlansoprazole - 138530-94-6 - Dexlansoprazole - 313640-86-7 DMF Sesquihydrate Dexrabeprazole Sodium - 171440-18-9 ODMF, Tech Pack E Ecabet Sodium - 86408-72-2 DMF Esomeprazole - 119141-88-7 - Esomeprazole Magneisum - 217087-10-0 - Dihydrate Esomeprazole Magnesium - 161973-10-0 - Esomeprazole Magnesium USP 217087-09-7 CEP, DMF Trihydrate Esomeprazole Potassium IHS 161796-84-5 DMF Esomeprazole Sodium - 161796-78-7 - Esomeprazole Zinc/ 793668-08-3, - - Base/Strontium 119141-88-7 F Famotidine - 76824-35-6 - E Glycopyrrolate - 596-51-0 - H Hydrotelcite BP 12304-65-3 - I Ilaprazole IHS, IP 172152-36-2 DMF Ilaprazole Sodium - 172152-50-0 ODMF, Tech Pack Itopride - 122898-67-3 - Itopride Hydrochloride IHS 122892-31-3 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 1 API Acid Reflux Disorders Product Pharmacopoeia CAS No. Technical Document L Lafutidine - 118288-08-7 - Lansoprazole - 103577-45-3 - Lansoprazole Sodium - 226904-00-3 - M Magaldrate USP 74978-16-8 - Misoprostol 1% dispersion - 51922-46-2 - in HPMC 1H NMR, CoA, HPLC, Nizatidine - 76963-41-2 N Mass, IR O Omeprazole - 73590-58-6 - Omeprazole Magnesium - 95382-33-5 - Omeprazole Sodium - 95510-70-6 - Oxethazaine - 126-27-2 - Oxyphenonium Bromide - 50-10-2 - P Pantoprazole EP, USP 102625-70-7 - Pantoprazole Magnesium - 471293-63-7 - Pantoprazole Sodium - 138786-67-1 ODMF, Tech Pack Pantoprazole Sodium 164579-32-2, - - Sesquihydrate 154644-14-1 Pirenzepine Dihydrochloride EP 29868-97-1 USFDA Monohydrate Propantheline Bromide - 50-34-0 - R Rabeprazole - 117976-89-3 - Rabeprazole Sodium - 117976-90-6 - Ranitidine - 66357-35-5 - Ranitidine Hydrochloride - 66357-59-3 - 90098-04-7, Rebamipide - - 111911-87-6 Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 2 API Acid Reflux Disorders Product Pharmacopoeia CAS No. Technical Document Roxatidine Acetate - 93793-83-0 - Hydrochloride S Siltenzepine - 98374-54-0 - Sucralfate BP, EP, JP, USP 54182-58-0 - T Tenatoprazole Sodium - 335299-59-7 ODMF, Tech Pack Troxipide - 30751-05-4 - V Vonoprazan Base - 881681-00-1 - Vonoprazan Fumarate - 881681-01-2 - Z Zinc L-Carnosine - 132613-07-1 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 3 API Allergy Management Product Pharmacopoeia CAS No. Technical Document A Acrivastine IHS 87848-99-5 ISO Adrenaline Acid Tartrate USP 51-42-3 - Alimemazine BP, EP 84-96-8 - Alinastine - 154541-72-7 - Asapiprant - 932372-01-5 - B Bamifylline Hydrochloride - 20684-06-4 - Bamirastine - 215529-47-8 - Bepotastine Besylate - 190786-44-8 - Bilastine - 202189-78-4 - Bilastine N-Oxide - 2069238-47-5 - Bromophenaromine BP, EP, USP 980-71-2 - Maleate C Carbinoxamine Maleate - 3505-38-2 USDMF Cetirizine Dihydrochloride BP, USP 83881-52-1 WC Chlorpheniramine Maleate BP, USP 113-92-8 EDMF, USDMF D Desloratadine - 100643-71-8 USMDF Dimetindene Maleate - 3614-69-5 CEP Diphenhydramine - 58-73-1 - Diphenhydramine Citrate USP 88637-37-0 - Diphenhydramine BP, IP, USP 147-24-0 - Hydrochloride Doxylamine Succinate EP, USP 562-10-7 WC E Ebastine BP, EP, USP 90729-43-4 WC Ebastine Fumarate - 97928-20-6 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 4 API Allergy Management Product Pharmacopoeia CAS No. Technical Document Embramine - 3565-72-8 - Embramine Hydrochloride - 13977-28-1 - Episnastine Hydrochloride - 108929-04-0 - F Fexofenadine Base - 83799-24-0 - Fexofenadine Hydrochloride - 153439-40-8 - 1244-76-4, Hydroxyzine Hydrochloride - - H 2192-20-3 K Ketotifen Fumarate - 34580-14-8 - L Levocetirizine - 130018-77-8 USDMF Levocetirizine - 130018-87-0 - Dihydrochloride Levocetirizine BP, EP, IP, JP, USP 823178-28-5 - Hydrochloride Loratadine - 79794-75-5 - M Mepyramine Maleate BP, EP 59-33-6 - Mequitazine BP, EP, USP 29216-28-2 GMP Methdilazine Hydrochloride - 1229-35-2 ISO9001 Mizolastine - 108612-45-9 - Oxomemazine - 4784-40-1 - O Hydrochloride P Pheniramine Maleate BP, EP, USP 132-20-7 - Phenylephrine BP, IP, USP 59-42-7 - Phenylephrine Bitartarate BP, USP 14787-58-7 - Phenylephrine - 61-76-7 - Hydrochloride S Suplatast Tosilate - 94055-76-2 - T Thozylamine - 91-85-0 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 5 API Allergy Management Product Pharmacopoeia CAS No. Technical Document Triprolidine Hydrochloride BP, EP, USP 6138-79-0 WC Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 6 API Anaemia Management Product Pharmacopoeia CAS No. Technical Document A Argatroban USP 141396-28-3 - C Calcium Folinate USP 1492-18-8 GMP, WHO-GMP Calcium Levofolinate - 80433-71-2 cGMP D Daprodustat - 960539-70-2 - Deferasirox - 201530-41-8 - F Ferric Carboxy Maltose - 9007-72-1 - Ferric Citrate - 3522-50-7 - Ferric Maltol - 33725-54-1 - Ferrocenecarboxaldehyde - 12093-10-6 cGMP, ISO Ferrous Ascorbate - 24808-52-4 - Ferrous Fumarate BP, IP, USP 141-01-5 - Ferrous Sodium Citrate - 144314-88-5 - Ferrous Succinate - 10030-90-7 - Ferrous Sulphate - 7720-78-7 DC-Grade Ferrous Sulphate Dried - 13463-43-9 - Ferumoxytol - 722492-56-0 - Folic Acid EP, BP, USP 59-30-3 DMF, CEP Iron III Hydroxide Poly - 1310-14-1 - I Maltose Complex Iron Isomaltoside - 1370654-58-2 - Iron Polymaltose Complex - 53858-86-9 - Iron Sorbitol IHS 1338-16-5 - Iron Sucrose - 8047-67-4 DMF, WC Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 7 API Anaemia Management Product Pharmacopoeia CAS No. Technical Document Iron(III) Hydroxide - 20344-49-4 - Iron(III) Hydroxypolymaltose IHS 79173-09-4 - Iron-Dextran - 9004-66-4 - M Methylcobalamin Hydrate - 288315-09-3 - Methylene Blue - 7220-79-3 - Methylthioninium Chloride BP, EP 122965-43-9 - DMF, ISO14001:2004, N Nandrolone Decanoate - 360-70-3 ISO9001:2008, Tech Pack, USFDA DMF, ISO14001:2004, Nandrolone Laurate BP, EP, IP, USP 26490-31-3 ISO9001:2008, Tech Pack, USFDA P Phytonadione (Vitamin K1) - 84-80-0 - R Rivipansel Sodium - 1189037-60-2 ISO Roxadustat - 808118-40-3 - S Sevelamer Carbonate - 845273-93-0 DMF Sevelamer Hydrochloride - 152751-57-0 DMF Sodium Ferric Gluconate - 34089-81-1 - Complex Sucroferric Oxyhydroxide - 12134-57-5 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 8 API Anthelmintics Product Pharmacopoeia CAS No. Technical Document A Alibendol - 26750-81-2 - Avermectin (Abamectin) - 73989-17-0 - B Benznidazole - 22994-85-0 - Buparvaquone - 88426-33-9 - C Clorsulon - 60200-06-8 - Cymiazole - 61676-87-7 - D Diethyl Carbamazine Citrate BP, IP, USP 1642-54-2 - Diloxanide Furoate BP 3736-81-0 - F Febantel BP, EP, IP 58306-30-2 - Fenbendazole BP 43210-67-9 - Fexinidazole 59729-37-2 - I Ivermectin EP 7.0 70161-11-4 - L Levamisole 14769-73-4 - Levamisole Hydrochloride EP 16595-80-5 - Levamisole Phosphate 32093-35-9 - M Mebendazole BP, EP, USP 31431-39-7 - Mepacrine Hydrochloride - 6151-30-0 - Miltefosine - 58066-85-6 - Morantel Tartrate BP, EP, USP 26155-31-7 - Moxidectin - 113507-06-5 - N Niclosamide - 50-65-7 - Nifursemizone - 5579-89-5 - Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. 2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 9 API Anthelmintics Product Pharmacopoeia CAS No.